Gene · 3242
Papers1,367
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,367
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery, herbicidal activity evaluation, and mechanism of action of Heteroaryl chalcones as novel HPPD inhibitors. | Pestic Biochem Physiol | 2026 | 41350074 | PubTator, text mining | PubMed |
| HPD is an m6A Methyltransferase that Protects Colorectal Cancer Cells from Ferroptotic Cell Death by m6A Methylating SLC7A11/GPX4. | Adv Sci (Weinh) | 2026 | 41317403 | Swiss-Prot, curated | PubMed |
| In Silico Design and Validation of a Novel HPPD-Inhibiting Herbicide Candidate Based on Benzofuran and Arylthioacetic Acid Scaffolds. | Chem Biodivers | 2026 | 41247843 | PubTator, text mining | PubMed |
| Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAs. | Nat Biomed Eng | 2026 | 41152569 | PubTator, text mining | PubMed |
| Different Clinic, Different Diagnosis: Tyrosinemia Type 3. | Mol Syndromol | 2026 | 41064053 | PubTator, text mining | PubMed |
| Harliku (nitisinone): first FDA-approved disease-modifying therapy for alkaptonuria. | Ann Med Surg (Lond) | 2025 | 41377225 | PubTator, text mining | PubMed |
| Nitisinone treatment protect hereditary tyrosinemia type I patients against inflammation, DNA and protein oxidative damage by decreasing succinylacetone levels. | Metab Brain Dis | 2025 | 41003839 | PubTator, text mining | PubMed |
| Exploring the Potential of Genista ulicina Phytochemicals as Natural Biocontrol Agents: A Comparative In Vitro and In Silico Analysis. | Toxins (Basel) | 2025 | 41003516 | PubTator, text mining | PubMed |
| Identification and verification of hub biomarkers and immune-related pathways participating in the trabecular meshwork after using corticosteroid. | PLoS One | 2025 | 40996982 | PubTator, text mining | PubMed |
| Enhancing Monacolin K and GABA Biosynthesis in Monascus pilosus via GAD Overexpression: Multi-Omics Elucidation of Regulatory Mechanisms. | J Fungi (Basel) | 2025 | 40985421 | PubTator, text mining | PubMed |
| Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines. | J Inherit Metab Dis | 2025 | 40965374 | PubTator, text mining | PubMed |
| Metabolic signatures and a diagnostic model for citrin deficiency based on urinary organic acids. | Clin Transl Med | 2025 | 40947814 | PubTator, text mining | PubMed |
| Comparative transcriptomic analysis reveals bioluminescence-related genes in firely Pyrocoelia pectoralis. | Genomics | 2025 | 40858179 | PubTator, text mining | PubMed |
| The Ability of Neonatal Mice to Develop Immunity to Mycobacterium tuberculosis Shows Sex Differences, with Females Displaying Evidence of an Enhanced Immune Response. | J Cell Immunol | 2025 | 40822417 | PubTator, text mining | PubMed |
| Challenges in diagnosing hawkinsinuria in adulthood: 2 cases from a single family. | BMJ Case Rep | 2025 | 40789710 | PubTator, text mining | PubMed |
| Antioxidant capacity and esterase activity of serum albumin toward interaction with HPPD inhibitors: Multi-spectral and computational studies. | Chem Biol Interact | 2025 | 40759372 | PubTator, text mining | PubMed |
| A comparison of cell death pathways in three different kinds of human lung cancer cell lines following hematoporphyrin derivative-mediated photodynamic therapy. | Cancer Biol Ther | 2025 | 40751929 | PubTator, text mining | PubMed |
| The β-triketone, nitisinone, kills insecticide-resistant mosquitoes through cuticular uptake. | Parasit Vectors | 2025 | 40745331 | PubTator, text mining | PubMed |
| Identification and application of herbicide-resistant 4-hydroxyphenylpyruvate dioxygenase (HPPD) alleles via directed evolution. | Plant Biotechnol J | 2025 | 40601794 | PubTator, text mining | PubMed |
| HPD is an RNA-Binding Protein Sustaining Ovarian Cancer Cell Glycolysis, Tumor Growth, and Drug Resistance. | Adv Sci (Weinh) | 2025 | 40491422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3242/papers?page=2